Skip to main content
Log in

Bevacizumab/capecitabine

Bowel perforation: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Chakrabarti A, et al. Bevacizumab and capecitabine in relapsed platinum-resistant epithelial carcinoma of ovary: A retrospective study. Clinical Cancer Investigation Journal 8: 84-89, No. 3, Jun 2019. Available from: URL: http://doi.org/10.4103/ccij.ccij_31_19

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bevacizumab/capecitabine. Reactions Weekly 1810, 50 (2020). https://doi.org/10.1007/s40278-020-80070-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-020-80070-1

Navigation